Global market for 3D Bio printing is expected to reach $ 1,129.8 million by 2020

growing at an estimated CAGR of 15.6% from 2014 to 2020, according to a new study by Grand View Research, Inc.

further key findings from the study suggest:

  • Polymers dominated the raw materials market in terms of share at over 35% in 2013 owing to their high usage rates in printing bio-models. The market for ceramics is expected to grow at a lucrative CAGR of 15.6% during the forecast period as it is widely used to manufacture the tooth or the mandible (jaw bone). Both these raw materials have been included in the U.S. FDA’s list of approved materials to be used for manufacturing implants that will be in contact with the body for long duration of time.
  • Photo-polymerization dominated the overall technology market and was valued at over USD 140 million in 2013. This technology is used widely by research organizations and companies to manufacture efficient and accurate bio-models.
  • Laser beam melting is expected to be the fastest growing technology, at an estimated CAGR of over 16% from 2014 to 2020 on account of its growing demand in manufacturing orthopedic implants and hip stems
  • North America was the largest regional market in 2013, accounting for over 35% of global revenue owing to the presence of high patient awareness levels, increasing healthcare expenditure, sophisticated healthcare infrastructure and increasing investment in R&D facilities pertaining to the development of 3D technologies based products
  • Europe is expected to be the fastest growing regional market over the forecast period. Presence of a large number of R&D funding programs and increasing demand for customized medical devices in this region is expected to drive market growth over the next six years
  • Key participants of this market include Envision TEC, Stratasys Inc., Materialise NV, 3D Systems Software, Bio-Rad Laboratories, Organovo, SOLS, Simbionix, Metamason, RegenHU Ltd., Youbionic, Bio3D Technologies Pte Ltd, 3D Matters Pte Ltd., 3D Systems Corporation (3DS), Ekso Bionics, Roche Pharmaceuticals, Renishaw plc., Robohand, Delcam India, Worrell, mobileOCT, Archam, Rainbow Biosciences, ALD Vacuum Technologies, and 3T RPD Ltd.

For more information go to the site.